Image de couverture de livre

Assessment of Pharmacokinetics and Food Effect of AD‐109, a Novel Formulation of Rivaroxaban 18 mg

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Hyunwook Ryu, Joo‐Youn Cho, Taewon Lee, Jandee Kim, SeungHwan Lee
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Clinical and Translational Science
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Pioglitazone‐induced alterations of purine metabolism in healthy male subjects
par: Jihyun Kang, et autres
Publié: (2024)

Pharmacokinetic interactions between fexuprazan, a potassium‐competitive acid blocker, and nonsteroidal anti‐inflammatory drugs in healthy males
par: Heejae Won, et autres
Publié: (2024)

Exploration of Using an Open‐Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements
par: Ki Young Huh, et autres
Publié: (2025)

Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6 ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans
par: Sungyeun Bae, et autres
Publié: (2026)

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Topical Applications of Sodium Taurodeoxycholate, a Treatment for Atopic Dermatitis
par: Heejae Won, et autres
Publié: (2025)

Effect of SLC22A1 polymorphism on the pharmacokinetics of proguanil in Korean: A semi‐physiologic population pharmacokinetic approach
par: Juyoung Khwarg, et autres
Publié: (2024)

Evaluation of the Effect of Food and Formulation on the Pharmacokinetics of the SHP2 Inhibitor Migoprotafib Within a Phase I Study in Cancer Patients
par: Julia Suchomel, et autres
Publié: (2026)

Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects
par: Heejae Won, et autres
Publié: (2024)

Pharmacokinetics and Safety of Fixed‐Dose Versus Separate Enavogliflozin/Gemigliptin Combinations, and Food Effect on Enavogliflozin in Healthy Korean Subjects
par: Young‐Sim Choi, et autres
Publié: (2025)

Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study
par: Byung Hak Jin, et autres
Publié: (2024)

CRISPRi screening identifies PIKfyve as a co‐therapeutic target for obinutuzumab
par: Yerim Kim, et autres
Publié: (2025)

The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications
par: Virginia D. Schmith, et autres
Publié: (2026)

Open‐Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women
par: Andy Sykes, et autres
Publié: (2026)

Population Pharmacokinetic Model Assessment of the Effects of Body Weight on Risk of Drug–Drug Interactions After Posaconazole Discontinuation
par: Rebecca E. Wrishko, et autres
Publié: (2026)

Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction‐associated fatty liver disease
par: Minji Lee, et autres
Publié: (2024)

Pharmacokinetic comparison of subcutaneously administered CT‐P13 (biosimilar of infliximab) via autoinjector and pre‐filled syringe in healthy participants
par: Ye Chan Park, et autres
Publié: (2024)

Assessment of Food Effect and pH‐Dependent Drug–Drug Interactions of Fruquintinib in Healthy Subjects
par: Martha Gonzalez, et autres
Publié: (2025)

The Dorsal Forearm as a Novel Target for Intramuscular Injections: Clinical Pharmacokinetic Results With Naloxone
par: Thomas F. Krol, et autres
Publié: (2025)

Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma
par: Junyi Li, et autres
Publié: (2025)

Pharmacokinetics as a Biomarker
par: John A. Wagner, et autres
Publié: (2026)

Effects of a High‐Fat Meal on the Pharmacokinetics of Olverembatinib in Patients With Chronic Myeloid Leukemia
par: Hengbang Wang, et autres
Publié: (2026)

Large‐Scale Analysis of Age and Sex Effects on Corrected QT and JT Intervals: Insights From Hospital‐Based Controls and Moxifloxacin‐Treated Cases
par: Eunwoo Kim, et autres
Publié: (2025)

Long‐term effects of adjunctive eslicarbazepine acetate in adult Asian patients with refractory focal seizures: Post hoc analysis of a phase III trial
par: Sang Kun Lee, et autres
Publié: (2024)

Safety, Tolerability, and Pharmacokinetics of SC1011 (Sufenidone), a Novel Antifibrotic Small Molecule, in Phase 1 Studies in Healthy Subjects
par: Yun Liu, et autres
Publié: (2025)

CXCR5 and TLR4 signals synergistically enhance non‐small cell lung cancer progression
par: Ji Hye Shin, et autres
Publié: (2024)

Effect of Rifampicin on the Pharmacokinetics of Valemetostat and Its Primary Metabolite: A Phase 1 Study in Healthy Participants
par: Masaya Tachibana, et autres
Publié: (2025)

No Effect of Immunogenicity on Pharmacokinetics, Efficacy, and Safety of the Oligonucleotide Telomerase Inhibitor Imetelstat in Lower‐Risk Myelodysplastic Syndromes
par: Ashley L. Lennox, et autres
Publié: (2025)

Tailored chemotherapy: Innovative deep‐learning model customizing chemotherapy for high‐grade serous ovarian carcinoma
par: Se Ik Kim, et autres
Publié: (2024)

Safety, Pharmacokinetics and Target Engagement of a Novel Brain Penetrant RIPK1 Inhibitor (SIR9900) in Healthy Adults and Elderly Participants
par: Ofer Michael Gonen, et autres
Publié: (2025)

Effect of Cladribine Tablets on the Pharmacokinetics of a Combined Oral Contraceptive in Pre‐Menopausal Women With Relapsing Multiple Sclerosis
par: Robert Hermann, et autres
Publié: (2025)

Effect of E7777 Immunogenicity on Pharmacokinetics, Efficacy, and Safety in Adult Patients With Relapsed or Refractory Cutaneous T‐Cell Lymphoma
par: Theingi M. Thway, et autres
Publié: (2025)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial
par: Thomas Capozza, et autres
Publié: (2025)

Pharmacokinetic‐Pharmacodynamic Model of Paclitaxel‐Induced Peripheral Neuropathy
par: Yuchen Sun, et autres
Publié: (2025)

Genotype–Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
par: Jumar Etkins, et autres
Publié: (2025)

Pharmacokinetics of Belumosudil and Its Metabolites in Individuals With Hepatic Impairment
par: Olivier Schueller, et autres
Publié: (2025)

Association of changes in predicted body composition with subsequent risk of dementia
par: Sung Min Kim, et autres
Publié: (2024)

Population Pharmacokinetic–Pharmacodynamic Modeling of Granulocyte Colony‐Stimulating Factor to Optimize Dosing and Timing for CD34+ Cell Harvesting
par: Xu Jiang, et autres
Publié: (2025)

Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug–Drug Interaction Study in Patients With Non‐Hodgkin Lymphoma
par: Masaya Tachibana, et autres
Publié: (2025)

From Lab to Clinic: Effect of Academia–Industry Collaboration Characteristics on Oncology Phase 1 Trial Entry
par: Wonseok Yang, et autres
Publié: (2025)

Correction to “Genotype‐Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers”
Publié: (2026)